Anti-IGF2BP2/IMP-2 antibody [EPR6741(B)] (Ab124930)
IMP2, VICKZ2, IGF2BP2, Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, IMP-2, Hepatocellular carcinoma autoantigen p62, IGF-II mRNA-binding protein 2, VICKZ family member 2
详细信息
背景信息
What is this antibody validated in? Anti-IGF2BP2/IMP-2 antibody [EPR6741(B)] (ab124930) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of IGF2BP2/IMP-2? Anti-IGF2BP2/IMP-2 [EPR6741(B)] (ab124930) specifically detects a band for IGF2BP2/IMP-2 (UniProt: Q9Y6M1) at a molecular weight of 66kDa. Trusted by the scientific community Anti-IGF2BP2/IMP-2 [EPR6741(B)] (ab124930) was first used in a scientific publication in 2012 and has been cited over 20 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [EPR6741(B)] also available for your convenience: ab124930, Carrier free - ab246342, Alexa Fluor ® 488 - ab319129, Alexa Fluor ® 647 - ab322024 Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (61)
LINC01963 promotes pancreatic ductal adenocarcinoma proliferation via METTL3/IGF2BP2 axis-mediated mâ¶A modification of c-Myc.
LINC01963 通过 METTL3/IGF2BP2 轴介导的 mâ ¶C-Myc 修饰促进胰腺导管腺癌增殖。
O-GlcNAcylation of IGF2BP2 promotes angiogenesis after ischemic stroke by stabilizing PPP2CA in an m6A-dependent manner : O-GlcNAcylation of IGF2BP2 alleviates ischemic brain injury.
IGF2BP2 的 O-GlcNAc 化通过以 m6A 依赖的方式稳定 PPP2CA 来促进缺血性中风后的血管生成：IGF2BP2 的 O-GlcNAc 化可减轻缺血性脑损伤。
The circ_0042103/TAF15/NER axis regulates inflammation and DNA damage in pulpitis.
circ_0042103/TAF15/NER 轴调节牙髓炎中的炎症和 DNA 损伤。
Acute myeloid leukemia (AML)-derived bone mesenchymal stem cell exosomal METTL14 promotes AML cell growth and glycolysis by HOXA3/WNT7B axis.
急性髓系白血病 (AML) 来源的骨髓间充质干细胞外泌体 METTL14 通过 HOXA3/WNT7B 轴促进 AML 细胞生长和糖酵解。
Direct circMAN1A2(2,3,4,5)-CENPB mRNA interaction regulates cell proliferation and cancer progression.
circMAN1A2(2,3,4,5)-CENPB mRNA 直接相互作用调节细胞增殖和癌症进展。
N 6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/ Et-1 axis
库普弗细胞中 circDcbld2 的 N6-甲基腺苷修饰通过靶向 miR-144-3p/Et-1 轴促进肝纤维化
SNORA37/CMTR1/ELAVL1 feedback loop drives gastric cancer progression via facilitating CD44 alternative splicing
SNORA37/CMTR1/ELAVL1 反馈回路通过促进 CD44 可变剪接驱动胃癌进展
RNA-binding proteins hnRNPM and ELAVL1 promote type-I interferon induction downstream of the nucleic acid sensors cGAS and RIG-I
RNA 结合蛋白 hnRNPM 和 ELAVL1 促进核酸传感器 cGAS 和 RIG-I 下游的 I 型干扰素诱导
Circ-ITCH promotes the ubiquitination degradation of HOXC10 to facilitate osteogenic differentiation in disuse osteoporosis through stabilizing BRCA1 mRNA via IGF2BP2-mediated m(6)A modification.
Circ-ITCH 通过 IGF2BP2 介导的 m(6)A 修饰稳定 BRCA1 mRNA，从而促进 HOXC10 的泛素化降解，进而促进废用性骨质疏松症中的成骨分化
METTL3-mediated m6A modification of circCDKAL1 regulates macrophage M1 polarization and nasal epithelial cell barrier function in allergic rhinitis through IGF2BP2/JARID2/HMGB1 axis.
METTL3 介导的 circCDKAL1 的 m6A 修饰通过 IGF2BP2/JARID2/HMGB1 轴调节过敏性鼻炎中的巨噬细胞 M1 极化和鼻上皮细胞屏障功能
- 1
- 2
- 3
- 4
- 5
- 6
- 7